How many drugs treat Bacterial vaginosis?

Drug Landscape tracks 5 marketed treatments for Bacterial vaginosis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/bacterial-vaginosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Bacterial vaginosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bacterial vaginosis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Bacterial vaginosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Solosec	SECNIDAZOLE	Evofem Inc	Nitroimidazole Antimicrobial [EPC]		2017-01-01
Tindamax	TINIDAZOLE	Mission Pharma	Nitroimidazole Antimicrobial [EPC]		2004-01-01
Cleocin	clindamycin	Generic (originally Upjohn/Pfizer)	Lincosamide antibiotic	50S ribosomal protein L10	1970-01-01
Metro I.V. In Plastic Container	METRONIDAZOLE	Baxter	Nitroimidazole Antimicrobial [EPC]		1963-01-01
Metronidazol	Metronidazol	University of Oslo		Thioredoxin reductase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxter · 1 drug in Bacterial vaginosis
Evofem Inc · 1 drug in Bacterial vaginosis
Generic (originally Upjohn/Pfizer) · 1 drug in Bacterial vaginosis
Mission Pharma · 1 drug in Bacterial vaginosis
University of Oslo · 1 drug in Bacterial vaginosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Bacterial vaginosis:

Cite this brief

Drug Landscape (2026). Bacterial vaginosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/bacterial-vaginosis. Accessed 2026-06-10.

Bacterial vaginosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing